Insight Molecular Diagnostics INC. (IMDX) SEC Filings — 2024
26 SEC filings for Insight Molecular Diagnostics INC. (IMDX) in 2024.
Filings
- Oncocyte CORP SC 13G/A Filing — SC 13G/A · Dec 9, 2024
- Oncocyte CORP SC 13G Filing — SC 13G · Nov 14, 2024
- Oncocyte Corp Files 8-K on Financials — 8-K · Nov 12, 2024
- Oncocyte Corp Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Oncocyte CORP SC 13G/A Filing — SC 13G/A · Oct 24, 2024
- Oncocyte Corp Files 8-K on Director Changes & Compensation — 8-K · Oct 15, 2024
- Oncocyte CORP SC 13G Filing — SC 13G · Oct 9, 2024
- Oncocyte Corp Files 8-K: Material Agreement, Equity Sales — 8-K · Oct 3, 2024
- Oncocyte Corp Files Definitive Proxy Statement — DEF 14A · Sep 25, 2024
- Oncocyte Corp Files 8-K: Material Agreements Entered and Terminated — 8-K · Aug 9, 2024
- Oncocyte Corp Files 10-Q for Q2 2024 — 10-Q · Aug 8, 2024
- Oncocyte Corp Faces Delisting Concerns — 8-K · Jul 12, 2024
- Oncocyte Corp to be Acquired — 8-K · Jul 5, 2024
- Oncocyte Corp Files 8-K: Board & Executive Changes — 8-K · Jun 17, 2024
- Oncocyte Corp Elects New Directors, Reports Executive Compensation — 8-K · May 31, 2024
- Oncocyte Corp Appoints New Directors, Reports Executive Compensation — 8-K · May 23, 2024
- Oncocyte Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Oncocyte Corp Schedules 2024 Annual Shareholder Meeting — DEF 14A · Apr 29, 2024
- Oncocyte CORP SC 13G Filing — SC 13G · Apr 22, 2024
- Oncocyte CORP 10-K Filing — 10-K · Apr 16, 2024
- Broadwood Partners Amends Oncocyte Stake — SC 13D/A · Apr 15, 2024
- Oncocyte Corp Files 8-K: Material Agreement, Financials, Equity Sales — 8-K · Apr 12, 2024
- Oncocyte Corp Files 8-K: Material Agreement & Financials — 8-K · Apr 11, 2024
- Oncocyte CORP SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Oncocyte CORP SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Oncocyte Files 8-K for Jan 22 Event; Routine Disclosure — 8-K · Jan 23, 2024